Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Journal of Mass Spectrometry : JMS|July 19, 2011
Screening and rank ordering of reversible mechanism-based inhibitors of hepatitis C virus NS3 protease using electrospray ionization mass spectrometryYan-Hui Liu, Lata Ramanathan, Bruce Malcolm, et al.Bioorganic & Medicinal Chemistry Letters|October 15, 2013
Identification of 2-aminooxazole amides as acyl-CoA: diacylglycerol acyltransferase 1 (DGAT1) inhibitors through scaffold hopping strategyHyunjin M Kim, Michelle D Smith, Jae-Hun Kim, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a potent thiadiazole class of histamine h3 receptor antagonist for the treatment of diabetesAshwin U Rao, Ning Shao, Robert G Aslanian, et al.Bioorganic & Medicinal Chemistry Letters|June 13, 2020
Discovery of hydroxy pyrimidine Factor IXa inhibitorsCharles L Jayne, Teresa Andreani, Tin-Yau Chan, et al.Bioorganic & Medicinal Chemistry Letters|October 6, 2009
Tetrahydroquinoline sulfonamides as vasopressin 1b receptor antagonistsJack D Scott, Michael W Miller, Sarah W Li, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of SCH 900188: A Potent Hepatitis C Virus NS5B Polymerase Inhibitor Prodrug As a Development CandidateKevin X Chen, Srikanth Venkatraman, Gopinadhan N Anilkumar, et al.Bioorganic & Medicinal Chemistry Letters|November 23, 2011
II. Novel HCV NS5B polymerase inhibitors: discovery of indole C2 acyl sulfonamidesGopinadhan N Anilkumar, Oleg Selyutin, Stuart B Rosenblum, et al.Journal of Medicinal Chemistry|January 18, 2012
A novel class of highly potent irreversible hepatitis C virus NS5B polymerase inhibitorsKevin X Chen, Charles A Lesburg, Bancha Vibulbhan, et al.Journal of Medicinal Chemistry|December 14, 2011
Structure-activity relationship (SAR) development and discovery of potent indole-based inhibitors of the hepatitis C virus (HCV) NS5B polymeraseKevin X Chen, Bancha Vibulbhan, Weiying Yang, et al.Bioorganic & Medicinal Chemistry Letters|November 21, 2013
Discovery of an irreversible HCV NS5B polymerase inhibitorQingbei Zeng, Anilkumar G Nair, Stuart B Rosenblum, et al.Pageof 2